Following its purchase of Affidea in April for 1 billion euros, Belgian investment firm Groupe Bruxelles Lambert (GBL) has initiated top leadership changes at the company.
Guy Blomfield, former CEO of Alliance Medical Group, has been named Affidea's interim CEO for the foreseeable future and will also serve as chairman of a new supervisory board. He will continue to develop Affidea's business in its existing markets as well as seek expansion opportunities in new markets that correspond to GBL's long-term investment horizon, the company said.
Former Affidea CEO Giuseppe Recchi will pursue other opportunities while remaining closely involved with Affidea as a nonexecutive member of the supervisory board.
Blomfield, a British national, has considerable professional experience spanning from managing partner roles in consultancy to top management and advisory roles at companies such as Oasis Dental Care and BMI Healthcare. Between 2011 and 2018, he led Alliance Medical Group, one of the leading providers of imaging services in Europe. Blomfield holds a Master of Science degree from the London School of Economics.
